Yue Chen

Prof. Yue Chen

College of Biological Sciences, University of Minnesota at Twin Cities, Minneapolis, MN 55455, USA
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2016 in Journal of Proteome Research
Verified
Journal Article
Closed access
TZTong Zhou
Tong Zhou
YCYing-Hua Chung
Ying-Hua Chung
JCJianji Chen
Jianji Chen
Yue ChenYue Chen
Yue Chen

13 October 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
TZTong Zhou
Tong Zhou
LELuke Erber
Luke Erber
BLBING LIU
BING LIU
YGYankun Gao
Yankun Gao
HRHai-Bin Ruan
Hai-Bin Ruan
Yue ChenYue Chen
Yue Chen
Proteomic analysis reveals diverse proline hydroxylation-mediated oxygen-sensing cellular pathways in cancer cells Proteomic analysis reveals diverse proline hydroxylation-mediated oxygen-sensing cellular pathways in cancer cells

1 September 2019 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
LELuke Erber
Luke Erber
ALAng Luo
Ang Luo
Yue ChenYue Chen
Yue Chen
Proline hydroxylation is a critical cellular mechanism regulating energy homeostasis and development. Our previous study identified and validated Bromodomain-containing protein 4 (BRD4) as a proline hydroxylation substrate in cancer cells. Yet, the regulatory mechanism and the functional significance of the modification remain unknown. In this study, we developed targeted quantification assays using parallel-reaction monitoring and biochemical analysis to identify the major regulatory enzyme of BRD4 proline hydroxylation. We further performed quantitative interactome analysis to determine the functional significance of the modification pathway in BRD4-mediated protein-protein interactions and gene transcription. Our findings revealed that PHD2 is the key regulatory enzyme of BRD4 proline hydroxylation and the modification significantly affects BRD4 interactions with key transcription factors as well as BRD4-mediated transcriptional activation. Taken together, this study provided mechanistic insights into the oxygen-dependent modification of BRD4 and revealed new roles of the pathway in regulating BRD4-dependent gene expression. Graphical Abstract Highlights BRD4 interaction with prolyl hydroxylase domain proteins. Stoichiometric dynamics and site-specific regulation of BRD4 proline hydroxylation. BRD4 interactome analysis in response to prolyl hydroxylase activity. Proline hydroxylation pathway regulation of BRD4-mediated transcriptional activity.

4 October 2020 in Cells
Verified
Journal Article
Open access
PDF file
NMNiko Moses
Niko Moses
MZMu Zhang
Mu Zhang
JWJheng-Yu Wu
Jheng-Yu Wu
CHChen Hu
Chen Hu
SXShengyan Xiang
Shengyan Xiang
Xiaohong (Mary) ZhangXiaohong (Mary) Zhang
Xiaohong (Mary) Zhang
We have previously discovered that HDAC6 regulates the DNA damage response (DDR) via modulating the homeostasis of a DNA mismatch repair protein, MSH2, through HDAC6’s ubiquitin E3 ligase activity. Here, we have reported HDAC6’s second potential E3 ligase substrate, a critical cell cycle checkpoint protein, Chk1. We have found that HDAC6 and Chk1 directly interact, and that HDAC6 ubiquitinates Chk1 in vivo and in vitro. Specifically, HDAC6 interacts with Chk1 via the DAC1 domain, which contains its ubiquitin E3 ligase activity. During the cell cycle, Chk1 protein levels fluctuate, peaking at the G2 phase, subsequently resolving via the ubiquitin-proteasome pathway, and thereby allowing cells to progress to the M phase. However, in HDAC6 knockdown non-small cell lung cancer (NSCLC) cells, Chk1 is constitutively active and fails to resolve post-ionizing radiation (IR), and this enhanced Chk1 activity leads to preferential G2 arrest in HDAC6 knockdown cells accompanied by a reduction in colony formation capacity and viability. Depletion or pharmacological inhibition of Chk1 in HDAC6 knockdown cells reverses this radiosensitive phenotype, suggesting that the radiosensitivity of HDAC6 knockdown cells is dependent on increased Chk1 kinase activity. Overall, our results highlight a novel mechanism of Chk1 regulation at the post-translational level, and a possible strategy for sensitizing NSCLC to radiation via inhibiting HDAC6’s E3 ligase activity.

15 November 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
YLYunan Li
Yunan Li
JEJonathan Evers
Jonathan Evers
ALAng Luo
Ang Luo
LELuke Erber
Luke Erber
ZPZachary Postler
Zachary Postler
Yue ChenYue Chen
Yue Chen

1 December 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
AHAmy Hauck
Amy Hauck
TZTong Zhou
Tong Zhou
AUAmbuj Upadhyay
Ambuj Upadhyay
YSYuxiang Sun
Yuxiang Sun
MOMichael B. O’connor
Michael B. O’connor
DBDavid Bernlohr
David Bernlohr
Oxidative stress is a hallmark of metabolic disease, though the mechanisms that define this link are not fully understood. Irreversible modification of proteins by reactive lipid aldehydes (protein carbonylation) is a major consequence of oxidative stress in adipose tissue and the substrates and specificity of this modification are largely unexplored. Here we show that histones are avidly modified by 4-hydroxynonenal (4-HNE) in vitro and in vivo. Carbonylation of histones by 4-HNE increased with age in male flies and visceral fat depots of mice and was potentiated in genetic (ob/ob) and high-fat feeding models of obesity. Proteomic evaluation of in vitro 4-HNE- modified histones led to the identification of both Michael and Schiff base adducts. In contrast, mapping of sites in vivo from obese mice exclusively revealed Michael adducts. In total, we identified 11 sites of 4-hydroxy hexenal (4-HHE) and 10 sites of 4-HNE histone modification in visceral adipose tissue. In summary, these results characterize adipose histone carbonylation as a redox-linked epigenomic mark associated with metabolic disease and aging.